癌症恶病质的影像学诊断与监测
本文综述了用于癌症恶病质诊断与监测的影像学方法,包括CT、MRI、18F-FDG PET和双能X线吸收法。通过分析身体成分和组织变化,这些方法有望用于恶病质表型分型和判断起病。文章还讨论了各技术的局限性及在肿瘤学中的适用性。
要点
- CT、MRI、18F-FDG PET和DXA可用于评估癌症恶病质的身体成分变化。
- 脂肪组织、器官和肌肉的定量与定性变化可能成为恶病质生物标志物。
- 各影像技术均有局限性,需结合临床常规护理权衡使用。
核心结论
- 影像学身体成分分析对癌症恶病质的表型分型和起病判断具有重要前景。
研究设计与样本
- 本文为综述,检索并比较了用于癌症恶病质评估的影像学技术。
主要发现
- 癌症恶病质主要涉及瘦体重的进行性丢失,与异常代谢和全身炎症相关。
- CT、MRI、18F-FDG PET和DXA可详细分析身体成分和组织变化。
- 脂肪组织、器官和肌肉的定量与定性变化可能是恶病质的重要生物标志物。
临床怎么用
- 可利用CT、MRI、18F-FDG PET或DXA评估身体成分,辅助恶病质的早期发现和个体化治疗。
局限性
- 各影像技术存在各自局限性,在临床常规护理中应用面临挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cachexia, a multifactorial wasting syndrome, is highly prevalent among advanced-stage cancer patients. Unlike weight loss in healthy humans, the progressive loss of body weight in cancer cachexia primarily implicates lean body mass, caused by an aberrant metabolism and systemic inflammation. This may lead to disease aggravation, poorer quality of life, and increased mortality. Timely detection is, therefore, crucial, as is the careful monitoring of cancer progression, in an effort to improve management, facilitate individual treatment and minimize disease complications. A detailed analysis of body composition and tissue changes using imaging modalities-that is, computed tomography, magnetic resonance imaging, (18F) fluoro-2-deoxy-D-glucose (18FDG) PET and dual-energy X-ray absorptiometry-shows great premise for charting the course of cachexia. Quantitative and qualitative changes to adipose tissue, organs, and muscle compartments, particularly of the trunk and extremities, could present important biomarkers for phenotyping cachexia and determining its onset in patients. In this review, we present and compare the imaging techniques that have been used in the setting of cancer cachexia. Their individual limitations, drawbacks in the face of clinical routine care, and relevance in oncology are also discussed.
引用
- Han J, Harrison L, Patzelt L, et al. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res. 2021. PMID: 34557972. doi:10.1186/s13550-021-00834-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。